vs
Side-by-side financial comparison of MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) and Quipt Home Medical Corp. (QIPT). Click either name above to swap in a different company.
MARAVAI LIFESCIENCES HOLDINGS, INC. is the larger business by last-quarter revenue ($49.9M vs $49.0M, roughly 1.0× Quipt Home Medical Corp.). Quipt Home Medical Corp. runs the higher net margin — -2.1% vs -71.6%, a 69.4% gap on every dollar of revenue. On growth, Quipt Home Medical Corp. posted the faster year-over-year revenue change (32.3% vs -11.8%). Quipt Home Medical Corp. produced more free cash flow last quarter ($6.9M vs $-24.9M).
Maravai LifeSciences Holdings is a global life sciences firm developing critical reagents, diagnostic products, and tech solutions to support biopharma research, drug development, clinical diagnostics, and cell/gene therapy manufacturing. It serves biotech, pharma, research bodies and labs worldwide across three core segments.
Quipt Home Medical Corp is a U.S.-based home medical equipment provider specializing in respiratory care, sleep therapy supplies, and chronic disease management products. It serves patients with long-term health conditions, partners with healthcare providers and insurance payers across operating regions to deliver accessible in-home medical solutions.
MRVI vs QIPT — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $49.9M | $49.0M |
| Net Profit | $-35.7M | $-1.1M |
| Gross Margin | 25.8% | 53.5% |
| Operating Margin | -117.9% | 2.1% |
| Net Margin | -71.6% | -2.1% |
| Revenue YoY | -11.8% | 32.3% |
| Net Profit YoY | -37.7% | 2.9% |
| EPS (diluted) | $-0.24 | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $49.9M | $49.0M | ||
| Q3 25 | $41.6M | $39.8M | ||
| Q2 25 | $47.4M | $35.1M | ||
| Q1 25 | $46.9M | $33.3M | ||
| Q4 24 | $56.6M | $37.1M | ||
| Q3 24 | $69.0M | — | ||
| Q2 24 | $69.4M | — | ||
| Q1 24 | $64.2M | — |
| Q4 25 | $-35.7M | $-1.1M | ||
| Q3 25 | $-25.6M | $-3.5M | ||
| Q2 25 | $-39.6M | $-3.0M | ||
| Q1 25 | $-29.9M | $-3.0M | ||
| Q4 24 | $-25.9M | $-1.1M | ||
| Q3 24 | $-97.1M | — | ||
| Q2 24 | $-9.8M | — | ||
| Q1 24 | $-12.1M | — |
| Q4 25 | 25.8% | 53.5% | ||
| Q3 25 | 13.6% | 48.7% | ||
| Q2 25 | 16.4% | 57.6% | ||
| Q1 25 | 16.5% | 54.6% | ||
| Q4 24 | 34.3% | 52.1% | ||
| Q3 24 | 46.7% | — | ||
| Q2 24 | 44.4% | — | ||
| Q1 24 | 40.3% | — |
| Q4 25 | -117.9% | 2.1% | ||
| Q3 25 | -98.6% | -3.6% | ||
| Q2 25 | -139.8% | -5.2% | ||
| Q1 25 | -104.9% | -3.0% | ||
| Q4 24 | -66.7% | 1.2% | ||
| Q3 24 | -239.9% | — | ||
| Q2 24 | -19.4% | — | ||
| Q1 24 | -29.4% | — |
| Q4 25 | -71.6% | -2.1% | ||
| Q3 25 | -61.4% | -8.9% | ||
| Q2 25 | -83.5% | -8.6% | ||
| Q1 25 | -63.9% | -9.1% | ||
| Q4 24 | -45.8% | -2.9% | ||
| Q3 24 | -140.6% | — | ||
| Q2 24 | -14.1% | — | ||
| Q1 24 | -18.8% | — |
| Q4 25 | $-0.24 | $-0.02 | ||
| Q3 25 | $-0.18 | $-0.07 | ||
| Q2 25 | $-0.27 | $-0.07 | ||
| Q1 25 | $-0.21 | $-0.07 | ||
| Q4 24 | $-0.21 | $-0.03 | ||
| Q3 24 | $-0.68 | — | ||
| Q2 24 | $-0.07 | — | ||
| Q1 24 | $-0.09 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $216.9M | $10.5M |
| Total DebtLower is stronger | $291.8M | $84.0M |
| Stockholders' EquityBook value | $212.4M | $113.0M |
| Total Assets | $770.6M | $280.7M |
| Debt / EquityLower = less leverage | 1.37× | 0.74× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $216.9M | $10.5M | ||
| Q3 25 | $243.6M | $12.9M | ||
| Q2 25 | $269.9M | $11.3M | ||
| Q1 25 | $285.1M | $17.1M | ||
| Q4 24 | $322.4M | $15.5M | ||
| Q3 24 | $578.2M | — | ||
| Q2 24 | $573.2M | — | ||
| Q1 24 | $561.7M | — |
| Q4 25 | $291.8M | $84.0M | ||
| Q3 25 | $292.8M | $87.6M | ||
| Q2 25 | $293.9M | $66.0M | ||
| Q1 25 | $294.9M | $71.5M | ||
| Q4 24 | $295.9M | $70.6M | ||
| Q3 24 | $521.7M | — | ||
| Q2 24 | $522.5M | — | ||
| Q1 24 | $523.3M | — |
| Q4 25 | $212.4M | $113.0M | ||
| Q3 25 | $245.4M | $112.1M | ||
| Q2 25 | $265.9M | $102.5M | ||
| Q1 25 | $300.6M | $103.6M | ||
| Q4 24 | $325.3M | $106.3M | ||
| Q3 24 | $344.9M | — | ||
| Q2 24 | $434.7M | — | ||
| Q1 24 | $410.7M | — |
| Q4 25 | $770.6M | $280.7M | ||
| Q3 25 | $849.2M | $283.3M | ||
| Q2 25 | $897.0M | $236.1M | ||
| Q1 25 | $959.8M | $244.6M | ||
| Q4 24 | $1.0B | $242.8M | ||
| Q3 24 | $1.3B | — | ||
| Q2 24 | $1.4B | — | ||
| Q1 24 | $1.4B | — |
| Q4 25 | 1.37× | 0.74× | ||
| Q3 25 | 1.19× | 0.78× | ||
| Q2 25 | 1.11× | 0.64× | ||
| Q1 25 | 0.98× | 0.69× | ||
| Q4 24 | 0.91× | 0.66× | ||
| Q3 24 | 1.51× | — | ||
| Q2 24 | 1.20× | — | ||
| Q1 24 | 1.27× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-22.8M | $8.9M |
| Free Cash FlowOCF − Capex | $-24.9M | $6.9M |
| FCF MarginFCF / Revenue | -49.9% | 14.0% |
| Capex IntensityCapex / Revenue | 4.2% | 4.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-70.7M | $26.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-22.8M | $8.9M | ||
| Q3 25 | $-15.2M | $9.8M | ||
| Q2 25 | $-10.3M | $9.7M | ||
| Q1 25 | $-9.4M | $8.9M | ||
| Q4 24 | $-14.6M | $9.3M | ||
| Q3 24 | $13.1M | — | ||
| Q2 24 | $17.4M | — | ||
| Q1 24 | $-8.5M | — |
| Q4 25 | $-24.9M | $6.9M | ||
| Q3 25 | $-18.1M | $8.0M | ||
| Q2 25 | $-13.1M | $4.4M | ||
| Q1 25 | $-14.6M | $7.3M | ||
| Q4 24 | $-20.5M | $5.6M | ||
| Q3 24 | $4.5M | — | ||
| Q2 24 | $7.9M | — | ||
| Q1 24 | $-14.1M | — |
| Q4 25 | -49.9% | 14.0% | ||
| Q3 25 | -43.4% | 20.0% | ||
| Q2 25 | -27.7% | 12.6% | ||
| Q1 25 | -31.2% | 22.0% | ||
| Q4 24 | -36.2% | 15.2% | ||
| Q3 24 | 6.6% | — | ||
| Q2 24 | 11.4% | — | ||
| Q1 24 | -22.0% | — |
| Q4 25 | 4.2% | 4.2% | ||
| Q3 25 | 7.0% | 4.6% | ||
| Q2 25 | 6.1% | 14.9% | ||
| Q1 25 | 11.2% | 4.8% | ||
| Q4 24 | 10.3% | 9.9% | ||
| Q3 24 | 12.4% | — | ||
| Q2 24 | 13.8% | — | ||
| Q1 24 | 8.8% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MRVI
| Cygnus Segment | $27.2M | 54% |
| Other | $18.4M | 37% |
| Shipping And Handling | $4.3M | 9% |
QIPT
Segment breakdown not available.
